See more : IHS Markit Ltd. (0UAI.L) Income Statement Analysis – Financial Results
Complete financial analysis of Pascal Biosciences Inc. (PSCBF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Pascal Biosciences Inc., a leading company in the Biotechnology industry within the Healthcare sector.
- Jewett-Cameron Trading Company Ltd. (JCTCF) Income Statement Analysis – Financial Results
- SMIFS Capital Markets Limited (SMIFS.BO) Income Statement Analysis – Financial Results
- Bombay Rayon Fashions Limited (BRFL.NS) Income Statement Analysis – Financial Results
- Big Tree Cloud Holdings Limited Warrants (DSYWW) Income Statement Analysis – Financial Results
- HarborOne Bancorp, Inc. (HONE) Income Statement Analysis – Financial Results
Pascal Biosciences Inc. (PSCBF)
About Pascal Biosciences Inc.
Pascal Biosciences Inc., a biotechnology company, engages in the research and development of products for the treatment of cancer, and for the improvement of the immune system. The company's development portfolio includes PAS-403, a mitosis inhibitor that blocks cell division for the treatment of glioblastoma and brain metastases originating from other cancers; and PAS-393, an immune-stimulatory cannabinoid designed to restore the immunogenicity of tumor cells with checkpoint inhibitor therapy for use in cancer treatment. It is also developing a B-cell targeted antibody for acute lymphoblastic leukemia and B cell lymphomas; and cannabinoid therapeutic products for the treatment of COVID-19. The company has an exclusive license agreement with the University of Washington to develop a cannabinoid-based product for the treatment of glioblastoma multiforme and brain metastases; and a collaborative research agreement with SoRSE Technology Corporation to advance PAS-393 into clinical testing. Pascal Biosciences Inc. was incorporated in 2011 and is headquartered in Seattle, Washington.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 670.16K | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 1.02M | 8.34K | 16.34K | 12.38K | 13.34K |
| Gross Profit | -345.42K | -8.34K | -16.34K | -12.38K | -13.34K |
| Gross Profit Ratio | -51.54% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 35.30K | -48.87K | 57.82K | 139.40K | 922.62K |
| General & Administrative | 1.28M | 614.23K | 1.05M | 1.38M | 0.00 |
| Selling & Marketing | 173.31K | -6.32K | 139.42K | 16.67K | 0.00 |
| SG&A | 515.12K | 600.24K | 1.01M | 1.11M | 2.43M |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 550.42K | 551.36K | 1.07M | 1.25M | 3.35M |
| Cost & Expenses | 1.57M | 559.70K | 1.08M | 1.26M | 3.37M |
| Interest Income | 0.00 | 1.41K | 0.00 | 412.80 | 17.87K |
| Interest Expense | 28.80K | 3.92K | 5.59K | 6.62K | 8.49K |
| Depreciation & Amortization | 106.71K | 8.34K | 16.34K | 12.38K | 13.34K |
| EBITDA | -789.13K | -497.51K | -1.07M | -1.25M | -3.35M |
| EBITDA Ratio | -117.75% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -895.84K | -559.70K | -1.08M | -1.26M | -3.37M |
| Operating Income Ratio | -133.68% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | 496.90K | 76.99K | -7.88K | 32.55K | -45.64K |
| Income Before Tax | -398.95K | -482.71K | -1.09M | -1.23M | -3.41M |
| Income Before Tax Ratio | -59.53% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 2.71 | -1.42K | 1.00 | -410.82 | -17.87K |
| Net Income | -398.95K | -482.71K | -1.09M | -1.23M | -3.41M |
| Net Income Ratio | -59.53% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | -0.02 | -0.04 | -0.09 | -0.11 | -0.32 |
| EPS Diluted | -0.02 | -0.04 | -0.09 | -0.11 | -0.32 |
| Weighted Avg Shares Out | 23.53M | 13.11M | 12.70M | 11.08M | 10.53M |
| Weighted Avg Shares Out (Dil) | 23.53M | 13.11M | 12.70M | 11.08M | 10.53M |
Nevis Brands CEO talks opportunity for THC beverage Major in California cannabis market
Nevis Brands achieves production and sales milestones for Major cannabis beverage in California
Nevis Brands continues to expand footprint in US with Missouri licensing agreement
Nevis Brands to bring Major cannabis beverage to Missouri
Nevis Brands expands cannabis beverages line in Ohio
Nevis Brands' flagship cannabis beverage Major set to stand out in growing Michigan market
Nevis Brands inks deal to bring Major branded cannabis products to Michigan
Nevis Brands eyes further expansion for Major after strong 3Q sales
Nevis Brands inks deal to bring Major branded cannabis beverages to California
Hardy Forzley Joins Pascal Biosciences as Chief Financial Officer
Source: https://incomestatements.info
Category: Stock Reports